FindTrial
Sign In

Accuracy of modified transperineal template-guided mapping biopsy for simulating the spatial distribution of prostate cancer

Accuracy of modified transperineal template-guided mapping biopsy for simulating the spatial distribution of prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013067
Enrollment
Unknown
Registered
2017-10-21
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:Prostate large slice technique is the gold standard for studying the spatial distribution of prostate cancer
Index test:N0

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who agree with any of the following four and agree to undergo TTMB puncture: 1. rectal examination found abnormal prostate; 2. prostate imaging abnormalities; 3. PSA > 10ng/ml; 4. PSA 4-10, abnormal f/t PSA or abnormal PSAD value.

Exclusion criteria

Exclusion criteria: 1. patients with abnormal coagulation function; 2. serious urinary tract infection; 3. severe cardiovascular and cerebrovascular diseases; 4. life expectancy is less than 10 years.

Design outcomes

Primary

MeasureTime frame
the accuracy of the spatial distribution of prostate cancer;—

Countries

China

Contacts

Public ContactDing Xuefei

Northern Jiangsu People's Hospital

Xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026